Randomized trial of vilazodone versus sertraline in depression: concerns and comments.
作者信息
Praharaj Samir Kumar
机构信息
Department of Psychiatry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
出版信息
Indian J Pharmacol. 2021 Mar-Apr;53(2):176-177. doi: 10.4103/ijp.IJP_288_20.
Abstract
摘要
相似文献
1
Randomized trial of vilazodone versus sertraline in depression: concerns and comments.维拉佐酮与舍曲林治疗抑郁症的随机试验：关注点与评论
Indian J Pharmacol. 2021 Mar-Apr;53(2):176-177. doi: 10.4103/ijp.IJP_288_20.
2
A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression.一项为期 12 周的前瞻性随机对照比较试验，比较了印度抑郁症患者使用维拉唑酮和舍曲林的效果。
Indian J Pharmacol. 2020 Jan-Feb;52(1):10-15. doi: 10.4103/ijp.IJP_618_18. Epub 2020 Mar 11.
3
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.伏硫西汀治疗重度抑郁症：与度洛西汀、艾司西酞普兰、左旋米那普明、舍曲林、文拉法辛和维拉唑酮的间接比较，采用治疗所需人数、伤害所需人数以及获益或伤害可能性进行分析
J Affect Disord. 2016 May 15;196:225-33. doi: 10.1016/j.jad.2016.02.042. Epub 2016 Feb 18.
4
Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor.SPARI 维拉佐酮的作用机制：5-羟色胺 1A 部分激动剂和再摄取抑制剂。
CNS Spectr. 2014 Apr;19(2):105-9. doi: 10.1017/S1092852914000169.
5
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.抑郁症、冠状动脉事件、血小板抑制与5-羟色胺再摄取抑制剂
Am J Cardiol. 1999 Aug 1;84(3):321-3, A8. doi: 10.1016/s0002-9149(99)00284-2.
6
Sertraline versus other antidepressive agents for depression.舍曲林与其他抗抑郁药治疗抑郁症的比较。
Cochrane Database Syst Rev. 2010 Jan 20(1):CD006117. doi: 10.1002/14651858.CD006117.
7
Sertraline versus other antidepressive agents for depression.舍曲林与其他抗抑郁药治疗抑郁症的比较。
Cochrane Database Syst Rev. 2009 Apr 15(2):CD006117. doi: 10.1002/14651858.CD006117.pub2.
8
The discovery and development of vilazodone for the treatment of depression: a novel antidepressant or simply another SSRI?维拉佐酮治疗抑郁症的发现和研发：新型抗抑郁药还是仅仅是另一种 SSRI？
Expert Opin Drug Discov. 2013 Dec;8(12):1529-39. doi: 10.1517/17460441.2013.855195. Epub 2013 Nov 7.
9
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.一项随机对照试验，评估在因抑郁症就诊于初级保健机构的人群中，与舍曲林相比安慰剂产生临床显著反应时所伴随的抑郁症状的严重程度和持续时间（PANDA试验）：一项随机对照试验的研究方案
Trials. 2017 Oct 24;18(1):496. doi: 10.1186/s13063-017-2253-4.
10
The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.维拉唑酮治疗重度抑郁症的临床前及临床疗效
Expert Opin Drug Discov. 2016;11(5):515-23. doi: 10.1517/17460441.2016.1160051. Epub 2016 Mar 16.
本文引用的文献
1
A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression.一项为期 12 周的前瞻性随机对照比较试验，比较了印度抑郁症患者使用维拉唑酮和舍曲林的效果。
Indian J Pharmacol. 2020 Jan-Feb;52(1):10-15. doi: 10.4103/ijp.IJP_618_18. Epub 2020 Mar 11.
2
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.CONSORT 2010 解释与说明：平行组随机试验报告的更新指南。
J Clin Epidemiol. 2010 Aug;63(8):e1-37. doi: 10.1016/j.jclinepi.2010.03.004. Epub 2010 Mar 25.
Zotero 插件